Publikationen

1.

Zeitschriftenartikel

Krauter, D.; Stausberg, D.; Hartmann, T. J.; Volkmann, S.; Kungl, T.; Rasche, D. A.; Saher, G.; Fledrich, R.; Stassart, R.M.; Nave, K.-A. et al.; Göbbels, S.; Ewers, D.; Sereda, M. W.: Targeting PI3K/Akt/mTOR signaling in rodent models of PMP22 gene-dosage diseases. Embo Molecular Medicine 16, S. 616 - 640 (2024)

MPG.PuRe

DOI

publisher-version

2.

Zeitschriftenartikel

Sundaram, V. K.; Schütza, V.; Schröter, N. H.; Backhaus, A.; Bilsing, A.; Joneck, L.; Seelbach, A.; Mutschler, C.; Gomez-Sanchez, J. A.; Schäffner, E. et al.; Sánchez, E. E.; Akkermann, D.; Paul, C.; Schwagarus, N.; Müller, S.; Odle, A.; Childs, G.; Ewers, D.; Kungl, T.; Sitte, M.; Salinas, G.; Sereda, M. W.; Nave, K.-A.; Schwab, M. H.; Ost, M.; Arthur-Farraj, P.; Stassart, R. M.; Fledrich, R.: Adipo-glial signaling mediates metabolic adaptation in peripheral nerve regeneration. Cell Metabolism 35 (12), S. 2136 - 2152.e9 (2023)

MPG.PuRe

DOI

publisher-version

3.

Zeitschriftenartikel

Berghoff, S. A.; Spieth, L.; Sun, T.; Hosang, L.; Schlaphoff, L.; Depp, C.; Düking, T.; Winchenbach, J.; Neuber, J.; Ewers, D. et al.; Scholz, P.; van der Meer, F.; Cantuti-Castelvetri, L.; Sasmita, A. O.; Meschkat, M.; Ruhwedel, T.; Möbius, W.; Sankowski, R.; Prinz, M.; Huitinga, I.; Sereda, M. W.; Odoardi, F.; Ischebeck, T.; Simons, M.; Stadelmann-Nessler, C.; Edgar, J. M.; Nave, K.-A.; Saher, G.: Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nature Neuroscience 24, S. 47 - 60 (2021)

MPG.PuRe

DOI

4.

Zeitschriftenartikel

Prukop, T.; Wernick, S.; Boussicault, L.; Ewers, D.; Jäger, K.; Adam, J.; Winter, L.; Quintes, S.; Linhoff, L.; Barrantes‐Freer, A. et al.; Bartl, M.; Czesnik, D.; Zschüntzsch, J.; Schmidt, J.; Primas, G.; Laffaire, J.; Rinaudo, P.; Brureau, A.; Nabirotchkin, S.; Schwab, M. H.; Nave, K.-A.; Hajj, R.; Cohen, D.; Sereda, M. W.: Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot–Marie–Tooth disease type 1A (CMT1A) rats. Journal of Neuroscience Research 98 (10), S. 1933 - 1952 (2020)

MPG.PuRe

DOI

publisher-version

5.

Zeitschriftenartikel

Rudnik‐Schöneborn, S.; Thiele, S.; Walter, M. C.; Reinecke, L.; Sereda, M. W.; Schöneborn, R.; Elbracht, M.: Pregnancy outcome in Charcot–Marie–Tooth disease: results of the CMT‐NET cohort study in Germany. European Journal of Neurology 27 (8), S. 1390 - 1396 (2020)

MPG.PuRe

DOI

publisher-version

6.

Zeitschriftenartikel

Siems, S. B.; Jahn, O.; Eichel, M. A.; Kannaiyan, N.; Wu, L. M. N.; Sherman, D. L.; Kusch, K.; Hesse, D.; Jung, R. B.; Fledrich, R. et al.; Sereda, M. W.; Rossner, M. J.; Brophy, P. J.; Werner, H. B.: Proteome profile of peripheral myelin in healthy mice and in a neuropathy model. eLife 9, e51406 (2020)

MPG.PuRe

DOI

publisher-version

7.

Zeitschriftenartikel

Joseph, S.; Vingill, S.; Jahn, O.; Fledrich, R.; Werner, H. B.; Katona, I.; Möbius, W.; Mitkovski, M.; Huang, Y.; Weis, J. et al.; Sereda, M. W.; Schulz, J. B.; Nave, K.-A.; Stegmüller, J.: Myelinating glia-specific deletion of Fbxo7 in mice triggers axonal degeneration in the central nervous system together with peripheral neuropathy. The Journal of Neuroscience 39 (28), S. 5606 - 5626 (2019)

MPG.PuRe

DOI

8.

Zeitschriftenartikel

Fledrich, R.; Akkermann, D.; Schütza, V.; Abdelaal, T. A. M.; Hermes, D.; Schäffner, E.; Soto Bernardini, M. C.; Götze, T.; Klink, A.; Kusch, K. et al.; Krueger, M.; Kungl, T.; Frydrychowicz, C.; Möbius, W.; Brück, W.; Mueller, W. C.; Bechmann, I.; Sereda, M. W.; Schwab, M. H.; Nave, K.-A.; Stassart, R. M.: NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies. Nature Communications 10, 1467 (2019)

MPG.PuRe

DOI

publisher-version

9.

Zeitschriftenartikel

Prukop, T.; Stenzel, J.; Wernick, S.; Kungl, T.; Mroczek, M.; Adam, J.; Ewers, D.; Nabirotchkin, S.; Nave, K.-A.; Hajj, R. et al.; Cohen, D.; Sereda, M. W.: Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A). PLoS One 14 (1), e0209752 (2019)

MPG.PuRe

DOI

publisher-version

10.

Zeitschriftenartikel

Fledrich, R.; Abdelaal, T. A. M.; Rasch, L.; Bansal, V.; Schütza, V.; Brügger, B.; Lüchtenborg, C.; Prukop, T.; Stenzel, J.; Rahman, R.U. et al.; Hermes, D.; Ewers, D.; Möbius, W.; Ruhwedel, T.; Katona, I.; Weis, J.; Klein, D.; Martini, R.; Brück, W.; Müller, W.C.; Bonn, S.; Bechmann, I.; Nave, K.-A.; Stassart, R. M.; Sereda, M. W.: Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy. Nature Communications 9, 3025 (2018)

MPG.PuRe

DOI

publisher-version

11.

Zeitschriftenartikel

Fledrich, R.; Mannil, M.; Leha, A.; Ehbrecht, C.; Solari, A.; Pelayo-Negro, A. L.; Berciano, J.; Schlotter-Weigel, B.; Schnizer, T. J.; Prukop, T. et al.; Garcia-Angarita, N.; Czesnik, D.; Haberlová, J.; Mazanec, R.; Paulus, W.; Beissbarth, T.; Walter, M. C.; CMT-TRIAAL; Hogrel, J.-Y.; Dubourg, O.; Schenone, A.; Baets, J.; De Jonghe, P.; Shy, M. E.; Horvath, R.; Pareyson, D.; Seeman, P.; Young, P.; Sereda, M. W.: Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A. Journal of Neurology, Neurosurgery & Psychiatry 88 (11), S. 941 - 952 (2017)

MPG.PuRe

DOI

supplementary-material

12.

Zeitschriftenartikel

Kleinecke, S.; Richert, S.; de Hoz, L.; Brügger, B.; Kungl, T.; Asadollahi, E.; Quintes, S.; Blanz, J.; McGonigal, R.; Naseri, K. et al.; Sereda, M. W.; Sachsenheimer, T.; Lüchtenborg, C.; Möbius, W.; Willison, H.; Baes, M.; Nave, K.-A.; Kassmann, C. M.: Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy. eLife 6, e23332 (2017)

MPG.PuRe

DOI

publisher-version

13.

Zeitschriftenartikel

Günther, R.; Balck, A.; Koch, J. C.; Nientiedt, T.; Sereda, M.; Bähr, M.; Lingor, P.; Tönges, L.: Rho kinase inhibition with Fasudil in SOD1(G93A) mouse model of Amyotrophic Lateral Sclerosis - symptomatic treatment potential after diesease onset. Frontiers in Pharmacology 8, 17 (2017)

MPG.PuRe

DOI

Full

14.

Zeitschriftenartikel

Sociali, G.; Visigalli, D.; Prukop, T.; Cervellini, I.; Mannino, E.; Venturi, C.; Bruzzone, S.; Sereda, M. W.; Schenone, A.: Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy. Neurobiology of Disease 95 (11), S. 145 - 157 (2016)

MPG.PuRe

DOI

15.

Zeitschriftenartikel

Quintes, S.; Brinkmann, B. G.; Ebert, M.; Fröb, F.; Kungl, T.; Arlt, F. A.; Tarabykin, V.; Huylebroeck, D.; Meijer, D.; Suter, U. et al.; Wegner, M.; Sereda, M. W.; Nave, K.-A.: Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair. Nature Neuroscience 19 (8), S. 1050 - 1059 (2016)

MPG.PuRe

DOI

16.

Zeitschriftenartikel

Pehlivan, D.; Beck, C. R.; Okamoto, Y.; Harel, T.; Akdemir, Z. H. C.; Jhangiani, S. N.; Withers, M. A.; Goksungur, M. T.; Carvalho, C. M. B.; Czesnik, D. et al.; Wiszniewski, W.; Muzny, D. M.; Gibbs, R. A.; Rautenstrauss, B.; Sereda, M. W.; Lupski, J. R.: The role of combined SNV and CNV burden in patients with distal symmetric polyneuropathy. Genetics in Medicine 18 (5), S. 443 - 451 (2016)

MPG.PuRe

DOI

17.

Zeitschriftenartikel

Patzig, J.; Kusch, K.; Fledrich, R.; Eichel, M. A.; Lüders, K. A.; Möbius, W.; Sereda, M. W.; Nave, K.-A.; Martini, R.; Werner, H. B.: Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking. Glia 64 (1), S. 155 - 174 (2016)

MPG.PuRe

DOI

18.

Zeitschriftenartikel

Epplen, D. B.; Prukop, T.; Nientiedt, T.; Albrecht, P.; Arlt, F. A.; Stassart, R. M.; Kassmann, C. M.; Methner, A.; Nave, K.-A.; Werner, H. B. et al.; Sereda, M. W.: Curcumin therapy in a Plp1 transgenic mouse model of Pelizaeus-Merzbacher disease. Annals of Clinical and Translational Neurology 2 (8), S. 787 - 796 (2015)

MPG.PuRe

DOI

publisher-version

19.

Zeitschriftenartikel

Ekins, S.; Litterman, N. K.; Arnold, R. J. G.; Burgess, R. W.; Freundlich, J. S.; Gray, S. J.; Higgins, J. J.; Langley, B.; Willis, D. E.; Notterpek, L. et al.; Pleasure, D.; Sereda, M. W.; Moore, A.: A brief review of recent Charcot-Marie-Tooth research and priorities. Faculty of 1000 Research 4, 53 (2015)

MPG.PuRe

DOI

publisher-version

20.

Zeitschriftenartikel

Chumakov, I.; Milet, A.; Cholet, N.; Primas, G.; Boucard, A.; Pereira, Y.; Graudens, E.; Mandel, J.; Laffaire, J.; Foucquier, J. et al.; Glibert, F.; Bertrand, V.; Nave, K.-A.; Sereda, M. W.; Vial, E.; Guedj, M.; Hajj, R.; Nabirotchkin, S.; Cohen, D.: Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Orphanet Journal of Rare Diseases 9 (1), 201 (2014)

MPG.PuRe

DOI

publisher-version

21.

Zeitschriftenartikel

Mannil, M.; Solari, A.; Leha, A.; Pelayo-Negro, A. L.; Berciano, J.; Schlotter-Weigel, B.; Walter, M. C.; Rautenstrauss, B.; Schnizer, T. J.; Schenone, A. et al.; Seeman, P.; Kadian, C.; Schreiber, O.; Angarita, N. G.; Fabrizi, G. M.; Gemignani, F.; Padua, L.; Santoro, L.; Quattrone, A.; Vita, G.; Calabrese, D.; CMT-TRIAAL/CMT-TRAUK Group; Young, P.; Laurà, M.; Haberlová, J.; Mazanec, R.; Paulus, W.; Beissbarth, T.; Shy, M. E.; Reilly, M. M.; Pareyson, D.; Sereda, M. W.: Selected items from the Charcot-Marie-Tooth (CMT) neuropathy score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients. Neuromuscular Disorders 24 (11), S. 1003 - 1017 (2014)

MPG.PuRe

DOI

22.

Zeitschriftenartikel

Avenali, L.; Narayanan, P.; Rouwette, T.; Cervellini, I.; Sereda, M.; Gomez-Varela, D.; Schmidt, M.: Annexin A2 regulates TRPA1-dependent nociception. Journal of Neuroscience 34 (44), S. 14506 - 14516 (2014)

MPG.PuRe

DOI

23.

Zeitschriftenartikel

Fledrich, R.; Stassart, R. M.; Klink, A.; Rasch, L. M.; Prukop, T.; Haag, L.; Czesnik, D.; Kungl, T.; Abdelaal, T. A. M.; Keric, N. et al.; Stadelmann, C.; Brück, W.; Nave, K.-A.; Sereda, M. W.: Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. Nature Medicine 20 (9), S. 1055 - 1061 (2014)

MPG.PuRe

DOI

24.

Zeitschriftenartikel

Prukop, T.; Epplen, D. B.; Nientiedt, T.; Wichert, S. P.; Fledrich, R.; Stassart, R. M.; Rossner, M. J.; Edgar, J. M.; Werner, H. B.; Nave, K.-A. et al.; Sereda, M. W.: Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model. The American Journal of Human Genetics 94 (4), S. 533 - 546 (2014)

MPG.PuRe

DOI

25.

Zeitschriftenartikel

Tönges, L.; Günther, R.; Suhr, M.; Jansen, J.; Balck, A.; Saal, K.-A.; Barski, E.; Nientied, T.; Götz, A. A.; Koch, J.-C. et al.; Mueller, B. K.; Weishaupt, J. H.; Sereda, M. W.; Hanisch, U.-K.; Bähr, M.; Lingor, P.: Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis. Glia 62 (2), S. 217 - 232 (2014)

MPG.PuRe

DOI

26.

Zeitschriftenartikel

Stassart, R. M.; Fledrich, R.; Velanac, V.; Brinkmann, B. G.; Schwab, M. H.; Meijer, D.; Sereda, M. W.; Nave, K.-A.: A role for Schwann cell-derived neuregulin-1 in remyelination. Nature Neuroscience 16 (1), S. 48 - 54 (2013)

MPG.PuRe

DOI

27.

Zeitschriftenartikel

Fledrich, R.; Stassart, R. M.; Sereda, M. W.: Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease. British Medical Bulletin 102 (1), S. 89 - 113 (2012)

MPG.PuRe

DOI

28.

Zeitschriftenartikel

Goebbels, S.; Oltrogge, J.; Wolfer, S.; Wieser, G. L.; Nientiedt, T.; Pieper, A.; Ruhwedel, T.; Groszer, M.; Sereda, M. W.; Nave, K.-A.: Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. Embo Molecular Medicine 4 (6), S. 486 - 499 (2012)

MPG.PuRe

DOI

publisher-version

29.

Zeitschriftenartikel

Fünfschilling, U.; Supplie, L. M.; Mahad, D.; Boretius, S.; Saab, A. S.; Edgar, J. M.; Brinkmann, B. G.; Kassmann, C. M.; Tzvetanova, I.; Möbius, W. et al.; Diaz, F.; Meijer, D.; Suter, U.; Hamprecht, B.; Sereda, M. W.; Moraes, C. T.; Frahm, J.; Goebbels, S.; Nave, K.-A.: Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485 (7399), S. 517 - 521 (2012)

MPG.PuRe

DOI

30.

Zeitschriftenartikel

Makoukji, J.; Belle, M.; Meffre, D.; Stassart, R.; Grenier, J.; Shackleford, G. G.; Fledrich, R.; Fonte, C.; Branchu, J.; Goulard, M. et al.; de Waele, C.; Charbonnier, F.; Sereda, M. W.; Baulieu, E.-E.; Schumacher, M.; Bernard, S.; Massaad, C.: Lithium enhances remyelination of peripheral nerves. Proceedings of the National Academy of Sciences of the United States of America 109 (10), S. 3973 - 3978 (2012)

MPG.PuRe

DOI

31.

Zeitschriftenartikel

Fledrich, R.; Schlotter-Weigel, B.; Schnizer, T. J.; Wichert, S. P.; Stassart, R. M.; Meyer zu Hörste, G.; Klink, A.; Weiss, B. G.; Haag, U.; Walter, M. C. et al.; Rautenstrauss, B.; Paulus, W.; Rossner, M. J.; Sereda, M. W.: A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients. Brain 135 (1), S. 72 - 87 (2012)

MPG.PuRe

DOI

32.

Zeitschriftenartikel

Gess, B.; Röhr, D.; Fledrich, R.; Sereda, M. W.; Kleffner, I.; Humberg, A.; Nowitzki, J.; Strecker, J.-K.; Halfter, H.; Young, P.: Sodium-dependent vitamin C transporter 2 deficiency causes hypomyelination and extracellular matrix defects in the peripheral nervous system. The Journal of Neuroscience 31 (47), S. 17180 - 17192 (2011)

MPG.PuRe

DOI

33.

Zeitschriftenartikel

Meyer zu Hoerste, G.; Miesbach, T. A.; Müller, J. I.; Fledrich, R.; Stassart, R. M.; Kieseier, B. C.; Coleman, M. P.; Sereda, M. W.: The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration. Neurobiology of Disease 42 (1), S. 1 - 8 (2011)

MPG.PuRe

DOI

34.

Zeitschriftenartikel

Kassmann, C. M.; Quintes, S.; Rietdorf, J.; Möbius, W.; Sereda, M. W.; Nientiedt, T.; Saher, G.; Baes, M.; Nave, K.-A.: A role for myelin-associated peroxisomes in maintaining paranodal loops and axonal integrity. FEBS Letters 585 (14), S. 2205 - 2211 (2011)

MPG.PuRe

DOI

35.

Zeitschriftenartikel

Leal, A.; Huehne, K.; Bauer, F.; Sticht, H.; Berger, P.; Suter, U.; Morera, B.; Del Valle, G.; Lupski, J. R.; Ekici, A. et al.; Pasutto, F.; Endele, S.; Barrantes, R.; Berghoff, C.; Neundörfer, B.; Heuss, D.; Dorn, T.; Young, P.; Santolin, L.; Uhlmann, T.; Meisterernst, M.; Sereda, M.; Meyer zu Hörste, G.; Nave, K.-A.; Reis, A.; Rautenstrauss, B.: Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models. Neurogenetics 10 (4), S. 275 - 287 (2009)

MPG.PuRe

DOI

Full

publisher-version

36.

Zeitschriftenartikel

Schardt, A.; Brinkmann, B. G.; Mitkovski, M.; Sereda, M. W.; Werner, H. B.; Nave, K.-A.: The SNARE protein SNAP-29 interacts with the GTPase Rab3A: Implications for membrane trafficking in myelinating glia. Journal of Neuroscience Research 87 (15), S. 3465 - 3479 (2009)

MPG.PuRe

DOI

37.

Zeitschriftenartikel

Merkler, D.; Klinker, F.; Jürgens, T.; Glaser, R.; Paulus, W.; Brinkmann, B. G.; Sereda, M. W.; Stadelmann-Nessler, C.; Guedes, R. C. A.; Brück, W. et al.; Liebetanz, D.: Propagation of spreading depression inversely correlates with cortical myelin content. Annals of Neurology 66 (3), S. 355 - 365 (2009)

MPG.PuRe

DOI

38.

Zeitschriftenartikel

Brinkmann, B. G.; Agarwal, A.; Sereda, M. W.; Garratt, A. N.; Müller, T.; Wende, H.; Stassart, R. M.; Nawaz, S.; Humml, C.; Velanac, V. et al.; Radyushkin, K.; Goebbels, S.; Fischer, T. M.; Franklin, R. J.; Lai, C.; Ehrenreich, H.; Birchmeier, C.; Schwab, M. H.; Nave, K.-A.: Neuregulin-1/ErbB Signaling Serves Distinct Functions in Myelination of the Peripheral and Central Nervous System. Neuron 59 (4), S. 581 - 595 (2008)

MPG.PuRe

DOI

39.

Zeitschriftenartikel

Wessig, C.; Jestaedt, L.; Sereda, M. W.; Bendszus, M.; Stoll, G.: Gadofluorine M-enhanced magnetic resonance nerve imaging: Comparison between acute inflammatory and chronic degenerative demyelination in rats. Experimental Neurology 210 (1), S. 137 - 143 (2008)

MPG.PuRe

DOI

40.

Zeitschriftenartikel

Nave, K.-A.; Sereda, M. W.; Ehrenreich, H.: Mechanisms of Disease: inherited demyelinating neuropathies - from basic to clinical research. Nature Clinical Practice Neurology 3 (8), S. 453 - 464 (2007)

MPG.PuRe

DOI

41.

Zeitschriftenartikel

Ivanova, N.; Claeys, K. G.; Deconinck, T.; Litvinenko, I.; Jordanova, A.; Auer-Grumbach, M.; Haberlova, J.; Löfgren, A.; Smeyers, G.; Nelis, E. et al.; Mercelis, R.; Plecko, B.; Priller, J.; Zamecnik, J.; Ceulemans, B.; Erichsen, A. K.; Björck, E.; Nicholson, G.; Sereda, M. W.; Seeman, P.; Kremensky, I.; Mitev, V.; De Jonghe, P.: Hereditary spastic paraplegia 3A associated with axonal neuropathy. Archives of Neurology 64 (5), S. 706 - 713 (2007)

MPG.PuRe

DOI

42.

Zeitschriftenartikel

Meyer zu Hörste, G.; Prukop, T.; Liebetanz, D.; Möbius, W.; Nave, K.-A.; Sereda, M. W.: Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Annals of Neurology 61 (1), S. 61 - 72 (2007)

MPG.PuRe

DOI

43.

Zeitschriftenartikel

Meyer zu Hörste, G.; Prukop, T.; Nave, K.-A.; Sereda, M. W.: Myelin disorders: causes and perspectives of Charcot-Marie-Tooth neuropathy. Journal of Molecular Neuroscience 28 (1), S. 77 - 88 (2006)

MPG.PuRe

DOI

44.

Zeitschriftenartikel

Sereda, M. W.; Nave, K.-A.: Animal models of Charcot-Marie-Tooth disease type 1A. Neuromolecular Medicine 8 (1-2), S. 205 - 215 (2006)

MPG.PuRe

DOI

45.

Zeitschriftenartikel

Vigo, T.; Nobbio, L.; Van Hummelen, P.; Abbruzzese, M.; Mancardi, G. L.; Verpoorten, N.; Verhoeven, K.; Sereda, M. W.; Nave, K.-A.; Timmerman, V. et al.; Schenone, A.: Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis. Molecular and Cellular Neuroscience 28 (4), S. 703 - 714 (2005)

MPG.PuRe

DOI

46.

Zeitschriftenartikel

Meyer zu Hörste, G.; Sereda, M. W.: Genetische Defekte der Myelinbildung: Molekulare Pathogenese der Charcot-Marie-Tooth Neuropathie (CMT1A). Neuroforum 1, S. 25 - 30 (2005)

MPG.PuRe

DOI

publisher-version

47.

Zeitschriftenartikel

Grandis, M.; Leandri, M.; Vigo, T.; Cilli, M.; Sereda, M. W.; Gherardi, G.; Benedetti, L.; Mancardi, G.; Abbruzzese, M.; Nave, K.-A. et al.; Nobbio, L.; Schenone, A.: Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. Experimental Neurology 190 (1), S. 213 - 223 (2004)

MPG.PuRe

DOI

48.

Zeitschriftenartikel

Michailov, G. V.; Sereda, M. W.; Brinkmann, B. G.; Fischer, T. M.; Haug, B.; Birchmeier, C.; Role, L.; Lai, C.; Schwab, M. H.; Nave, K.-A.: Axonal Neuregulin-1 Regulates Myelin Sheath Thickness. Science 304 (5671), S. 700 - 703 (2004)

MPG.PuRe

DOI

49.

Zeitschriftenartikel

Sereda, M. W.; Meyer zu Hörste, G.; Suter, U.; Uzma, N.; Nave, K.-A.: Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nature Medicine 9 (12), S. 1533 - 1537 (2003)

MPG.PuRe

DOI

50.

Zeitschriftenartikel

Schneider, S.; Bosse, F.; D'Urso, D.; Müller, H.-W.; Sereda, M. W.; Nave, K.-A.; Niehaus, A.; Kempf, T.; Schnölzer, M.; Trotter, J.: The AN2 Protein Is a Novel Marker for the Schwann Cell Lineage Expressed by Immature and Nonmyelinating Schwann Cells. The Journal of Neuroscience 21 (3), S. 920 - 933 (2001)

MPG.PuRe

DOI

Publikationen

Zeitschriftenartikel (50)